Cite
HARVARD Citation
Hoste, J. et al. (2014). Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE): post-hoc subanalysis of the Belgian data. Acta clinica belgica. 69 (3), pp. 171-176. [Online].